3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, Trine Vang Skjøth et al.|The Lancet|2017Cited by 857
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 TrialHelena W. Rodbard, Е. О. Филиппова, Julio Rosenstock et al.|Diabetes Care|2019Cited by 442
Mediterranean Diet and Healthy Ageing: A Sicilian PerspectiveSonya Vasto, Calogero Caruso, Silvio Buscemi et al.|Gerontology|2014Cited by 96
Contents Vol. 60, 2014Michael H. Schwenk, Satz Mengensatzproduktion, Klaus Hauer et al.|Gerontology|2014Cited by 0